NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Skitahoe: common sense says transportablity is a tertiary consideration and removed from these higher considerations:

Foremost is certification upon INITIAL installation.

Like most precision tools for medicine highly unlikely any institution would even VENTURE
for consideration when the costs of an EDEN unit is LOW versus the transport cost logistics & TANTAMOUNT are:
•the accuracy impinging on
•the quality &
•success of NWBO's DC VAX PLATFORM.
Moreover
•Unlikely any Regulatory Agency would approve given a potpourri of ensuing issues

So my view
Skitahoe's suggestion is DEAD on ARRIVAL

DIFFERENT STROKES for DIFFERENT FOLKS